Qlife Holding AB - Asset Resilience Ratio

Latest as of March 2023: 15.26%

Qlife Holding AB (QLIFE) has an Asset Resilience Ratio of 15.26% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Qlife Holding AB (QLIFE) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Skr29.09 Million
≈ $3.13 Million USD Cash + Short-term Investments

Total Assets

Skr190.64 Million
≈ $20.52 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Qlife Holding AB's Asset Resilience Ratio has changed over time. See QLIFE book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Qlife Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see QLIFE market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr29.09 Million 15.26%
Total Liquid Assets Skr29.09 Million 15.26%

Asset Resilience Insights

  • Good Liquidity Position: Qlife Holding AB maintains a healthy 15.26% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Qlife Holding AB Industry Peers by Asset Resilience Ratio

Compare Qlife Holding AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Beijing Wandong Medical Technology Co Ltd
SHG:600055
Medical Devices 4.92%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
MODULIGHT OY EO 1
F:78W
Medical Devices 22.31%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.39%
Theradiag SA
PA:ALTHE
Medical Devices 15.59%
Nova EYE Medical Ltd
AU:EYE
Medical Devices 11.08%

Annual Asset Resilience Ratio for Qlife Holding AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Qlife Holding AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About Qlife Holding AB

ST:QLIFE Sweden Medical Devices
Market Cap
$3.24 Million
Skr30.07 Million SEK
Market Cap Rank
#29090 Global
#664 in Sweden
Share Price
Skr1.92
Change (1 day)
+1.70%
52-Week Range
Skr1.26 - Skr5.00
All Time High
Skr16052.19
About

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vit… Read more